Who owns Cue Biopharma Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cue Biopharma stock

Who bought or sold Cue Biopharma Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Bleichroeder 6.8M $2.1M 0% Dec 2025
 View chart
Catalytic Wealth RIA 4.6M $1.4M 35% Dec 2025
 View chart
Vanguard Group 3.0M $919k -1% Dec 2025
 View chart
Vanguard Capital Management 2.5M $565k 100% Mar 2026
 View chart
Lion Point Capital 2.2M $506k 0% Mar 2026
 View chart
Geode Capital Management 1.1M $245k 33% Mar 2026
 View chart
Vanguard Fiduciary Trust 544k $125k 100% Mar 2026
 View chart
Robertson Stephens Wealth Management 479k $110k 0% Mar 2026
 View chart
BlackRock 449k $103k 0% Mar 2026
 View chart
Texas Capital Bank Wealth Management Services 397k $91k -10% Mar 2026
 View chart
Angeles Wealth Management 310k $71k 0% Mar 2026
 View chart
Advisory Research 257k $79k 0% Dec 2025
 View chart
Stifel Financial 247k $57k 0% Mar 2026
 View chart
Renaissance Technologies 238k $73k 5% Dec 2025
 View chart
Bank of America Corporation 208k $48k 100% Mar 2026
 View chart
State Street Corporation 179k $55k -5% Dec 2025
 View chart
Susquehanna International 169k $52k 1% Dec 2025
 View chart
Northern Trust 101k $31k 0% Dec 2025
 View chart
UBS Group 88k $20k 89% Mar 2026
 View chart
Chicago Partners Investment 86k $50k 0% Mar 2026
 View chart
Northwestern Mutual Wealth Management Company 80k $18k 0% Mar 2026
 View chart
Advisortrust Partners 50k $12k 100% Mar 2026
 View chart
Sigma Planning 39k $8.9k -6% Mar 2026
 View chart
Goldman Sachs Group 34k $7.9k 138% Mar 2026
 View chart
Persistent Asset Partners 33k $7.7k 100% Mar 2026
 View chart
Visionary Wealth Advisors 29k $6.7k 100% Mar 2026
 View chart
GSA Capital Partners 20k $5.0k 100% Mar 2026
 View chart
Cambridge Investment Research Advisors 20k $5.0k 0% Mar 2026
 View chart
Goss Wealth Management 20k $4.6k 0% Mar 2026
 View chart
Prevail Innovative Wealth Advisors 19k $4.4k 0% Mar 2026
 View chart
Morgan Stanley 18k $4.2k -1% Mar 2026
 View chart
LPL Financial 16k $3.6k -66% Mar 2026
 View chart
Vanguard Global Advisers 13k $3.0k 100% Mar 2026
 View chart
Citadel Advisors 13k $2.9k 100% Mar 2026
 View chart
SeaCrest Wealth Management 10k $2.3k 0% Mar 2026
 View chart
Barclays 6.0k $1.8k 0% Dec 2025
 View chart
Gleason Group 6.0k $1.4k 0% Mar 2026
 View chart
New Millennium Group 5.8k $1.8k 100% Dec 2025
 View chart
Newbridge Financial Services Group 3.0k $690.000000 0% Mar 2026
 View chart
Wells Fargo & Company 2.6k $588.977400 0% Mar 2026
 View chart
Simplex Trading 2.6k $779.885000 -47% Dec 2025
 View chart
Golden State Wealth Management 2.0k $460.000000 0% Mar 2026
 View chart
UMA Financial Services 1.0k $231.983600 0% Mar 2026
 View chart
Mather Group 1.0k $230.000000 100% Mar 2026
 View chart
Advisor Group Holdings 680.00 $208.556000 0% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 415.00 $94.993500 0% Mar 2026
 View chart
Jones Financial Companies, L.L 400.00 $122.000000 100% Dec 2025
 View chart
MAI Wealth Advisors 350.00 $80.990000 0% Mar 2026
 View chart
Armstrong Advisory Group 120.00 $27.996000 0% Mar 2026
 View chart
IFP Advisors 100.00 $23.000000 0% Mar 2026
 View chart
Royal Bank of Canada 75.00 $0 100% Mar 2026
 View chart

Who sold out of Cue Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Boothbay Fund Management Dec 2025 704k $215k
Jane Street Dec 2025 70k $21k
Hrt Financial Dec 2025 21k $6.0k
Virtu Financial Sep 2025 15k $11k
XTX Topco Sep 2025 15k $11k
HighTower Advisors Dec 2025 11k $3.3k
Tower Research Capital Sep 2025 10k $7.3k
Tidemark Dec 2025 1.5k $457.950000
Jpmorgan Chase & Co Sep 2025 904.00 $649.976000
Advisory Services Network Sep 2025 200.00 $144.000000